# Alexander Parkhomenko

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alexander-parkhomenko/

## Facts

| Field | Value |
| --- | --- |
| Citations | 88,621 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 76 |
| i10-index | 124 |
| Last Known Institution | National Scientific Center "M.D. Strazhesko Institute of Cardiology" |
| OpenAlex ID | https://openalex.org/A5007989674 |
| ORCID iD | https://orcid.org/0000-0002-3563-9627 |
| Works | 306 |

## Researcher papers

Showing 12 of 21.

- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-5/)
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)
- [Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials](https://scholariq.org/papers/comparison-of-the-efficacy-and-safety-of-new-oral-anticoagulants-with-warfarin/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-4/)
- [Third Universal Definition of Myocardial Infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial](https://scholariq.org/papers/renal-outcomes-with-telmisartan-ramipril-or-both-in-people-at-high-vascular-risk/)
- [ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary](https://scholariq.org/papers/acc-aha-esc-guidelines-for-the-management-of-patients-with-atrial-fibrillation/)
- [Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency](https://scholariq.org/papers/beneficial-effects-of-long-term-intravenous-iron-therapy-with-ferric/)
- [Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation](https://scholariq.org/papers/antithrombotic-therapy-after-acute-coronary-syndrome-or-pci-in-atrial/)
- [Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome](https://scholariq.org/papers/apixaban-with-antiplatelet-therapy-after-acute-coronary-syndrome/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [National Scientific Center "M.D. Strazhesko Institute of Cardiology"](https://scholariq.org/institutions/national-scientific-center-m-d-strazhesko-institute-of-cardiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.